HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by Hsbc Holdings PLC

Hsbc Holdings PLC lessened its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 96.4% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 2,694 shares of the company’s stock after selling 71,248 shares during the quarter. Hsbc Holdings PLC’s holdings in HealthEquity were worth $259,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in HQY. Barclays PLC boosted its position in HealthEquity by 209.3% during the 3rd quarter. Barclays PLC now owns 166,492 shares of the company’s stock worth $13,628,000 after acquiring an additional 112,667 shares during the period. GAMMA Investing LLC lifted its holdings in HealthEquity by 32.9% in the fourth quarter. GAMMA Investing LLC now owns 1,248 shares of the company’s stock worth $120,000 after purchasing an additional 309 shares during the period. Nordea Investment Management AB lifted its holdings in HealthEquity by 4.8% in the fourth quarter. Nordea Investment Management AB now owns 59,812 shares of the company’s stock worth $5,747,000 after purchasing an additional 2,757 shares during the period. Assenagon Asset Management S.A. bought a new position in HealthEquity in the 4th quarter valued at about $1,452,000. Finally, Covea Finance acquired a new position in HealthEquity during the 4th quarter valued at about $1,727,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have recently issued reports on HQY. The Goldman Sachs Group decreased their price objective on shares of HealthEquity from $107.00 to $94.00 and set a “neutral” rating for the company in a report on Thursday, March 27th. Wells Fargo & Company lifted their price target on HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a research report on Wednesday, February 26th. KeyCorp cut their price objective on HealthEquity from $110.00 to $100.00 and set an “overweight” rating for the company in a report on Wednesday, April 16th. Barrington Research reaffirmed an “outperform” rating and set a $112.00 target price on shares of HealthEquity in a report on Friday, April 11th. Finally, Raymond James raised shares of HealthEquity from an “outperform” rating to a “strong-buy” rating and cut their price target for the company from $120.00 to $115.00 in a report on Tuesday, March 25th. One analyst has rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, HealthEquity has an average rating of “Buy” and a consensus price target of $111.75.

HealthEquity Trading Down 1.0 %

HealthEquity stock opened at $90.44 on Friday. HealthEquity, Inc. has a 52 week low of $65.01 and a 52 week high of $115.59. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The firm has a market capitalization of $7.82 billion, a price-to-earnings ratio of 82.97, a P/E/G ratio of 1.60 and a beta of 0.45. The company has a 50 day moving average price of $88.05 and a 200 day moving average price of $96.63.

Insiders Place Their Bets

In related news, EVP Michael Henry Fiore sold 8,881 shares of HealthEquity stock in a transaction dated Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the completion of the transaction, the executive vice president now directly owns 56,655 shares of the company’s stock, valued at $4,433,820.30. This trade represents a 13.55 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction that occurred on Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total transaction of $446,487.50. Following the sale, the director now directly owns 84,969 shares of the company’s stock, valued at approximately $6,597,842.85. The trade was a 6.34 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 20,381 shares of company stock valued at $1,781,432 over the last ninety days. Corporate insiders own 2.20% of the company’s stock.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.